These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 21683793)
1. The extraction, isolation and purification of an endogenous regulator for the 5-HT2 receptor. Apud JA Pharmacol Res; 2011 Oct; 64(4):312-3. PubMed ID: 21683793 [TBL] [Abstract][Full Text] [Related]
2. Changes in the rat brain 5-HT1A and 5-HT2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs. Klimek V; Zak-Knapik J; Cannizzaro C Pol J Pharmacol Pharm; 1992; 44(6):549-60. PubMed ID: 1305956 [TBL] [Abstract][Full Text] [Related]
3. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors. Lyon RA; Davis KH; Titeler M Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649 [TBL] [Abstract][Full Text] [Related]
4. The influences of reserpine and imipramine on the 5-HT2 receptor binding site and its coupled second messenger in rat cerebral cortex. Lee MJ; Wei JW Chin J Physiol; 2013 Aug; 56(4):199-208. PubMed ID: 23806035 [TBL] [Abstract][Full Text] [Related]
5. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. Branchek T; Adham N; Macchi M; Kao HT; Hartig PR Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697 [TBL] [Abstract][Full Text] [Related]
7. AT-1015, a newly synthesized 5-HT2 receptor antagonist, dissociates slowly from the 5-HT2 receptor sites in rabbit cerebral cortex membrane. Rashid M; Watanabe M; Nakazawa M; Nagatomo T J Pharm Pharmacol; 2002 Aug; 54(8):1123-8. PubMed ID: 12195828 [TBL] [Abstract][Full Text] [Related]
8. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain. Pranzatelli MR; Gregory CM Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108 [TBL] [Abstract][Full Text] [Related]
9. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. Klimek V; Zak-Knapik J; Mackowiak M J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368 [TBL] [Abstract][Full Text] [Related]
10. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex. Hoyer D; Vos P; Closse A; Palacios JM; Engel G; Davies H J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S48-50. PubMed ID: 2446070 [TBL] [Abstract][Full Text] [Related]
12. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding. Pranzatelli MR; Murthy JN; Pluchino RS J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361 [TBL] [Abstract][Full Text] [Related]
13. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. Kendall DA; Nahorski SR J Pharmacol Exp Ther; 1985 May; 233(2):473-9. PubMed ID: 2987487 [TBL] [Abstract][Full Text] [Related]
14. Activation of Gq proteins coupled with 5-HT2 receptors in rat cerebral cortical membranes assessed by antibody-capture scintillation proximity assay/[S]GTPĪ³S binding. Odagaki Y; Toyoshima R Pharmacology; 2013; 92(1-2):2-10. PubMed ID: 23860332 [TBL] [Abstract][Full Text] [Related]
15. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity. Killam AL; Nikam SS; Lambert GM; Martin AR; Nelson DL J Pharmacol Exp Ther; 1990 Mar; 252(3):1083-9. PubMed ID: 2319460 [TBL] [Abstract][Full Text] [Related]
16. Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles. Darchen F; Scherman D; Laduron PM; Henry JP Mol Pharmacol; 1988 Jun; 33(6):672-7. PubMed ID: 3380081 [TBL] [Abstract][Full Text] [Related]
17. Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle. Cohen ML; Schenck KW; Colbert W; Wittenauer L J Pharmacol Exp Ther; 1985 Mar; 232(3):770-4. PubMed ID: 3973826 [TBL] [Abstract][Full Text] [Related]
18. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636 [TBL] [Abstract][Full Text] [Related]
19. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. Lucki I; Nobler MS; Frazer A J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097 [TBL] [Abstract][Full Text] [Related]
20. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs. Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]